A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer

Clinical trial NCT07258407 · RECRUITING

Trial details

NCT number: NCT07258407
Sponsor: T.O.A.D. Oncology SA
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Castration-Resistant Prostatic Cancer

Start date: 2026-01-30
Primary completion: 2028-03-01
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.